Cardio-TriTest vs Vivid S60N

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Cardio-TriTest

by Cardio-Phoenix

Vivid S60N

by GE HealthCare

AI Verdict

These two tools are adjacent in their application, both leveraging AI for cardiovascular diagnosis but through different modalities. Cardio-TriTest focuses on combining and correlating multiple physiological signals (ECG, PCG, MCG) for early disease detection. In contrast, the Vivid S60N is an advanced ultrasound system specializing in AI-powered imaging and quantification for detailed anatomical and functional assessment.

Choose Cardio-TriTest if…

Choose Cardio-TriTest if your primary care clinic requires a comprehensive, non-invasive, and AI-powered tool for early and synchronized detection of cardiovascular diseases. This device is ideal for visually correlating multiple heart bio-signals (ECG, PCG, MCG) to provide a more holistic initial assessment of cardiac health.

View Cardio-TriTest →

Choose Vivid S60N if…

Choose the GE HealthCare Vivid S60N if your cardiology department needs an advanced ultrasound system for detailed diagnostic imaging, quantification, and treatment planning. This system excels in providing AI-powered 2D and 4D imaging with exceptional image quality and automated measurements, seamlessly integrating with hospital IT systems for efficient workflows.

View Vivid S60N →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Cardio-TriTest	Vivid S60N
Pricing	Unknown	Contact vendor for pricing
Deployment	On-premise (device)	On-premise (physical medical device)
FDA Status	Unknown	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Vivid S60N

Tool B (Vivid S60N) emphasizes an ergonomic design, intuitive user interface with touch screen and tactile buttons, and AI-enabled automation for measurements and workflow, directly enhancing the user experience for sonographers performing complex imaging tasks. While Tool A (Cardio-TriTest) offers a non-invasive and quick procedure, Tool B's features are more extensively detailed regarding ease of operation in a sophisticated diagnostic setting.

Clinical Value

Cardio-TriTest

Tool A (Cardio-TriTest / Cardio-HART) provides strong claims of 'echo-level insights at ECG speed' and 'clinically validated precision' with specific metrics like a +90% echo-agreement rate and 160% more confirmed diagnoses, backed by a multicenter study and peer-reviewed publication. While Tool B (Vivid S60N) offers advanced imaging and AI-powered quantification, its FDA 510(k) states it did not require clinical studies for substantial equivalence, and it does not present comparable specific clinical validation outcomes in the provided information.

Pricing & Value

Tie

Both Tool A (Cardio-TriTest) and Tool B (Vivid S60N) require direct contact with the vendor for pricing information, which is a common practice for medical devices. Without specific pricing details or comprehensive cost-benefit analyses for either product, it is not possible to determine a winner in this dimension.

Enterprise Readiness

Vivid S60N

Tool B (Vivid S60N) explicitly details DICOM connectivity for seamless integration with PACS/EMR systems, along with robust cybersecurity measures like SonoDefense and LDAP support, which are crucial for enterprise deployment and data management in hospital environments. Tool A (Cardio-TriTest) mentions HIPAA compliance and cloud processing but lacks specific information on its integration capabilities with existing hospital IT infrastructure.

Innovation

Cardio-TriTest

Tool A (Cardio-TriTest / Cardio-HART) demonstrates a highly innovative approach by combining three distinct bio-signals (ECG, PCG, MCG) with AI-powered analysis to provide comprehensive, 'echo-level insights' for earlier cardiovascular disease detection in primary care, effectively bridging a diagnostic gap. While Tool B (Vivid S60N) showcases significant advancements in ultrasound imaging and AI automation, Tool A's multi-modal, synchronized diagnostic paradigm represents a more fundamental novelty in its diagnostic method.

Support & Docs

Vivid S60N

Tool B (Vivid S60N), from GE HealthCare, offers extensive support resources including user and service manuals, an online community (Vivid Club), expert sessions (Vivid Talks), whitepapers, and automated software updates. Tool A (Cardio-TriTest) lacks detailed information on its support infrastructure and comprehensive documentation, making Tool B the clear winner in this dimension due to its well-established and diverse support offerings.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Cardio-TriTest	Vivid S60N
Product Name	Cardio-TriTest	Vivid S60N
Company	Cardio-Phoenix Inc.	GE HealthCare
Primary Function	AI-powered 3-in-1 diagnostic device combining ECG, PCG, and MCG for earlier and more comprehensive cardiovascular disease detection in primary care.	Advanced cardiovascular ultrasound systems featuring AI-powered imaging, automated measurements, and workflow enhancements for confident diagnosis and efficient patient care.
Core Diagnostic Modality	3-in-1 diagnostic device (ECG, PCG, MCG)	Advanced 2D and 4D ultrasound imaging capabilities
AI-Powered Capabilities	AI-powered analysis for heart disease detection; synchronizes and visually correlates heart bio-signals.	AI-powered imaging, automated measurements, and workflow enhancements.
Target Specialties	Cardiology, Family Medicine, Internal Medicine	Cardiology, Pediatrics, Radiology

Videos

Demos, reviews, and walkthroughs featuring Cardio-TriTest and Vivid S60N.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these tools integrate into existing clinical workflows for cardiovascular assessment, and what impact do they have on overall efficiency and required personnel?

Cardio-TriTest is a 3-in-1 diagnostic device designed for non-invasive, comprehensive cardiovascular disease detection, likely streamlining initial assessments in primary care with minimal specialized personnel. The Vivid S60N is an advanced ultrasound system with AI-enabled automation that enhances workflow efficiency for detailed cardiovascular imaging, typically requiring a trained sonographer or physician for operation and interpretation.

What is the depth of EHR integration for each tool, specifically regarding automated data transfer of results and images into patient records and reporting systems?

While Cardio-TriTest, as a diagnostic device, would generate reports, specific details on its automated EHR integration depth for direct data transfer are not provided. The Vivid S60N features DICOM connectivity, enabling seamless integration with reporting systems and EMRs for automated transfer of images and quantitative data into patient records.

How do the diagnostic capabilities and AI-powered analyses of each tool compare in terms of accuracy and sensitivity for detecting various cardiovascular conditions, and what unique clinical insights do they offer?

Cardio-TriTest provides synchronized bio-signal acquisition and visual correlation of ECG, PCG, and MCG for earlier and more comprehensive cardiovascular disease detection, offering a multi-modal view of heart function. The Vivid S60N offers advanced 2D and 4D ultrasound imaging with AI-enabled automation and quantification tools for confident diagnosis of heart function and valve anatomy, providing detailed anatomical and functional insights.

What is the expected learning curve for physicians and their staff to become proficient in operating each device and interpreting its results, and what ongoing training and support are provided?

Cardio-TriTest's non-invasive procedure and visual correlation features suggest a potentially manageable learning curve, especially for primary care settings, though specific training details are not provided. The Vivid S60N, while featuring AI-enabled automation to streamline tasks, is an advanced ultrasound system that would require a learning curve for proficient operation and interpretation, with vendor training typically provided for such devices.

Beyond standard compliance, what specific security measures and audit-trail features does each device offer to protect patient data during acquisition, processing, and transfer within the clinical environment?

Specific security measures beyond HIPAA compliance and audit-trail features are not detailed for Cardio-TriTest in the provided information. The Vivid S60N integrates with hospital IT systems (PACS/EMR) and handles PHI within a HIPAA-regulated environment, implying adherence to broader IT security protocols for data transfer and storage, though specific audit-trail features are not listed.

What are the key considerations for deploying each tool across multiple clinical sites, particularly regarding infrastructure, IT support, and standardization of protocols for a larger healthcare system?

Cardio-TriTest, as a device-based diagnostic tool, may be suitable for distributed deployment across multiple primary care sites, potentially simplifying multi-site rollouts for initial cardiovascular screening. The Vivid S60N, being a physical, on-premise ultrasound system, multi-site deployment would involve considerations for IT infrastructure, PACS/EMR integration across locations, and standardized imaging protocols, despite its exceptional mobility.